Cancer Biomarkers

The Cancer Biomarkers Research Group promotes research to identify, develop, and validate biological markers for early cancer detection and cancer risk assessment. Activities include development and validation of promising cancer biomarkers, collaborative databases and informatics systems, and new technologies or the refinement of existing technologies.

Read more About the Cancer Biomarkers Research Group.

Staff

Funding Opportunities

Grants

Publications

Alliance of Glycobiologists for Cancer Research

Tumor Glycomics Laboratories work to reveal cancer-related dynamics of complex carbohydrates.

Consortium for Imaging and Biomarkers (CIB)

Research Units integrate imaging strategies with biomarkers to improve cancer screening, early detection of aggressive cancer, assessment of cancer risk, and diagnosis of early stage cancer.

Early Detection Research Network (EDRN)

Labs and centers bring together comprehensive infrastructure and resources critical to discovery, development and validation of biomarkers for cancer risk and early detection.

Liquid Biopsy Consortium

A partnership with academic and industrial laboratory teams developing noninvasive liquid biopsy techniques to detect early stage cancer from biomarkers in blood, urine and sputum.

Pancreatic Cancer Detection Consortium (PCDC)

Research teams develop and test new molecular and imaging biomarkers to detect early stage pancreatic ductal adenocarcinoma and its precursor lesions.

Translational Liver Cancer (TLC) Consortium

Five Translational Research Centers conduct studies to improve surveillance of liver cancer in high-risk populations, increase detectability at early stages, and stratify at-risk patients.

Alliance of Pancreatic Cancer Consortia, and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting

Alliance of Pancreatic Cancer Consortia, and the European Liquid Biopsy Society Workshop on Extracellular Vesicles in Early Detection of Pancreatic Cancer meeting

This meeting will be held virtually via Zoom on Thursday, May 25 from 8:00 a.m. - 2:30 p.m. ET and Friday, May 26 from 8:00 a.m. - 12:30 p.m. ET. Registration is required.

News and Events

Could A Diabetes Diagnosis Help Detect Pancreatic Cancer Early?
Date Posted: July 7, 2021

The Search for Early Detection of Pancreatic Cancer Accelerates with Biomarkers
Date Posted: April 27, 2021

New Technology Gives Patients Access to a 5-Minute, Office-Based Test to Identify Risk for Esophageal Cancer
Date Posted: June 1, 2020

Taking Advantage of the Transportation Processes from Inside to Outside the Cell to Detect Cancer
Date Posted: December 11, 2019

New Onset Diabetes Cohort Sought to Unravel Complexities of Pancreatic Cancer Development
Date Posted: November 19, 2019